On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Masimo Corp. (MASI) on Tuesday reported a loss of $100.4 million in its third quarter. The Irvine, California-based company said it had a loss of $1.84 per ...

Irvine-based Masimo Corp. today announced a multi-year renewal of its strategic partnership with Royal Philips, a Dutch health technology company valued at $27 billion. The extension of the two-decade ...

Philips (NYSE: PHG) + and Masimo (Nasdaq: MASI) + today announced that they renewed their multi-year strategic patient monitoring collaboration. The two companies aim to accelerate the development and ...

Last week, when Apple announced the release of a “redesigned Blood Oxygen feature” to the Apple Watch, many figured Masimo (who had been suing Apple over patents related to the feature), would look ...

Masimo found out about restoration of pulse oximetry to the Apple Watch the same way that the rest of the world did, and is suing US Customs and Border Protection to stop the process. It seems Apple ...

Apple is preparing to appeal a trade ban that forced it to remove the blood oxygen sensor feature from the Apple Watch Series 9 and Ultra 2 models last year. The ban stemmed from a ruling by the ...

Apple is now planning to appeal an infamous ban that led to the Apple Watch Series 9 and Ultra 2 versions losing the blood oxygen sensor feature last year in court. The case saw the International ...